Vertex Pharmaceuticals (NQ:VRTX)

485.22 -21.78 (-4.30%)

Delayed Quote Updated: 4:00 PM EDT, Oct 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

77 78 Next >

BofA Unveils Q1 2026 Top Stock Picks: High-Conviction Bets on AI Infrastructure and Health Care Valuations

January 02, 2026

As the opening bells of 2026 ring across Wall Street, Bank of America Securities has released its highly anticipated "Top 10 U.S. Stock Ideas for Q1 2026." The report, a cornerstone for institutional...

Via MarketMinute

Topics Artificial Intelligence Economy

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Compelling Value Stock Candidate ↗

January 01, 2026

Via Chartmill

The Best Stocks to Invest $1,000 in to Start the New Year Off Right ↗

January 01, 2026

These three stocks could make 2026 a happy new year for investors.

Via The Motley Fool

Topics Artificial Intelligence

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Stay informed with the top movers within the S&P500 index on Tuesday. ↗

December 30, 2025

Via Chartmill

Discover which S&P500 stocks are making waves on Tuesday. ↗

December 30, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

2 Growth Stocks to Buy For 2026 and Beyond ↗

December 30, 2025

Neither had a great year in 2025, but the future is looking bright.

Via The Motley Fool

Topics Economy

2 Nasdaq 100 Stocks Worth Investigating and 1 We Turn Down

December 28, 2025

The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or...

Via StockStory

Topics Electric Vehicles World Trade

3 Supercharged Growth Stocks to Buy and Hold Into the 2030s ↗

December 28, 2025

Growth stocks fall in and out of favor with investors, but quality businesses are always worth buying.

Via The Motley Fool

Topics Artificial Intelligence

Forget Moderna Stock, This is a Much Better Buy ↗

December 27, 2025

This stock is a great choice for cautious and aggressive investors.

Via The Motley Fool

Topics Intellectual Property

The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy

December 24, 2025

On December 23, 2025, the biotechnology landscape shifted for thousands of patients living with chronic anemia. The U.S. Food and Drug Administration (FDA) granted approval to AQVESME (mitapivat),...

Via PredictStreet

Topics Economy

Is CRISPR Therapeutics Stock Yesterday's News? ↗

December 24, 2025

The biotech sells blood disorders treatment, Casgevy.

Via The Motley Fool

Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12

December 22, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive

December 22, 2025

As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global...

Via PredictStreet

Topics Earnings Initial Public Offering Intellectual Property

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A GARP Case Study in Affordable Growth ↗

December 22, 2025

Vertex Pharmaceuticals (VRTX) exemplifies GARP investing, offering strong earnings growth, top profitability, and a debt-free balance sheet at a reasonable market valuation.

Via Chartmill

2 Cash-Producing Stocks to Consider Right Now and 1 We Find Risky

December 21, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗

December 19, 2025

Next year could be crucial for the company as sales for its only approved treatment could take off.

Via The Motley Fool

2 Reasons to Watch VRTX and 1 to Stay Cautious

December 17, 2025

Since June 2025, Vertex Pharmaceuticals has been in a holding pattern, posting a small return of 0.5% while floating around $450.68. The stock also fell short of the S&P 500’s 13.6% gain during that...

Via StockStory

Topics Stocks

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

December 16, 2025

Issued on behalf of Avant Technologies Inc.

From USA News Group

Via GlobeNewswire

12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗

December 15, 2025

The following players span a variety of industries, so if you pick up more than one, you may gain in diversification.

Via The Motley Fool

Topics Artificial Intelligence

Vertex Pharmaceuticals (NASDAQ:VRTX) Combines Strong Growth with Technical Breakout Potential ↗

December 15, 2025

Vertex Pharmaceuticals (VRTX) shows strong growth fundamentals and a positive technical breakout setup, combining high earnings forecasts with a promising stock chart pattern.

Via Chartmill

2 Healthcare Stocks to Buy Ahead of the New Year ↗

December 12, 2025

These companies could innovate their way to success.

Via The Motley Fool

Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth

December 11, 2025

As 2025 draws to a close, a powerful undercurrent of technological innovation, extending far beyond the pervasive influence of artificial intelligence, is demonstrably reshaping the global stock...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

1 Large-Cap Stock to Consider Right Now and 2 Facing Challenges

December 08, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? ↗

December 06, 2025

The stock has fallen from a peak back in April.

Via The Motley Fool

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions

December 06, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

1 Reason I'll Never Sell Vertex Pharmaceuticals Stock ↗

December 04, 2025

The stock has climbed in the double-digits in recent years.

Via The Motley Fool

Topics Intellectual Property

Which S&P500 stocks are moving on Wednesday? ↗

December 03, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today

December 03, 2025

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and...

Via StockStory

Topics Artificial Intelligence Economy

What's going on in today's session: S&P500 movers ↗

December 03, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

77 78 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.